Business
Regeneron reported Q3 revenue of $5.116 billion and GAAP diluted EPS of $18.45, compared with non-GAAP EPS of $20.07. A separate $1 billion Sanofi collaboration payment is to be recognized in Q4, with additional milestones conditional on future events.
Business
Dominion's Q3 reported diluted EPS rose to $1.30, while operating EPS, its non-GAAP measure, was $1.28. The utility expects the upper half of its $3.45–$3.69 annual operating-EPS range; it has not provided an equivalent GAAP forecast.
Business
The US parent reported quarterly sales of $5.369 billion and diluted EPS of $0.94. Base Business non-GAAP EPS was $0.97. Its global results are separate from Colgate-Palmolive India's earlier quarterly results and rupee dividend announcement.
Business
Cboe's quarterly net revenue rose to $712.2 million. Reported diluted EPS of $4.08 was above adjusted EPS of $3.63, with the reported result including a divestiture gain. The exchange operator raised its annual organic-growth target and lowered its adjusted expense forecast.
Business
AbbVie's third-quarter revenue reached $17.404 billion. Reported diluted EPS was $2.37 and adjusted EPS was $3.82, with both measures including a $0.11 acquired-research and milestone expense impact. The annual forecast remains adjusted, not GAAP earnings guidance.
Business
Chevron reported $9.924 billion of third-quarter earnings, compared with $10.361 billion on its adjusted measure. Reported diluted EPS was $5.06, while adjusted EPS was $5.28; the release also set out future investment plans in Venezuela.
Business
ExxonMobil reported $15.4 billion of third-quarter earnings and $17.5 billion on its adjusted measure. It also announced a $20 billion 2027 buyback plan subject to reasonable market conditions and declared a $1.07 quarterly dividend.
Business
Intel reported revenue of $16.513 billion for its quarter ended 26 September. GAAP diluted EPS fell to $0.60, while non-GAAP EPS rose to $0.52. Its $15 billion–$16 billion Q4 revenue range is a forecast, not the latest quarterly result.
Business
Sanofi raised its full-year outlook after third-quarter sales grew 16.2% at actual exchange rates. IFRS shareholder profit rose 7.8%; the faster growth in its non-IFRS business earnings needs a separate comparison.
Business
Amazon's Q3 sales rose 12% to $201.9 billion and operating profit increased to $28.1 billion. Reported net income edged lower, while free cash flow for the trailing twelve months—not Q3 alone—was a $42.4 billion outflow as investment spending increased.
Business
Merck & Co.'s third-quarter sales grew 5% to $18.085 billion, while reported net income fell 12% to $5.065 billion. Non-GAAP profit also declined, and both earnings-per-share measures include a licensing charge.
Business
Caterpillar's third-quarter sales and revenues rose 17% to $20.7 billion. Operating profitability also improved, while the company's adjusted earnings exclude restructuring costs.